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ABsTRACT
Producing polyclonal antibodies (IgY) in 
chickens has advantages over those ob-
tained in other animal models, since they 
have been used as a tool for studying 
different proteins (NMDA glutamate re-
ceptor in our case, specifically the NR1 
subunit). We produced specific antibo-
dies against expression products by the 
alternative splicing of the gene encoding 
NMDA receptor NR1 subunit in adult rat 
brain. Three peptides corresponding to 
the splicing sites (N1, C1 and C2’ casset-
tes) were designed, synthesised and used 
individually as antigens in hens. Speci-
fic immunoglobulins were purified from 
yolks. The antibodies were then used for 
purifying the NMDA receptor NR1 subu-
nit using affinity chromatography cou-
pling the three antibodies to the support. 
Key words: IgY, antibody, glutama-
te, NMDA, NR1 subunit, affinity chro-
matography, purification.
REsumEn
La producción de anticuerpos policlona-
les en gallinas (IgY) tiene ventajas sobre 
anticuerpos obtenidos en otros modelos 
animales y se han empleado como una 
nueva herramienta para estudiar diferen-
tes proteínas (el receptor de glutamate 
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tipo NMDA en nuestro caso, específica-
mente la subunidad NR1). Produjimos 
anticuerpos específicos contra productos 
de expresión por splicing alternativo del 
gen que codifica la subunidad NR1 del 
receptor tipo NMDA en el cerebro de 
rata adulta. Se diseñaron 3 péptidos co-
rrespondientes a los sitios de splicing del 
gen (conocidos como casetes N1, C1 y 
C2´), se sintetizaron y se usaron indivi-
dualmente como antígenos en gallinas. 
Inmunoglobulinas específicas se purifi-
caron de las yemas. Los anticuerpos se 
usaron para purificar la subunidad NR1 
del receptor tipo NMDA usando croma-
tografía de afinidad, a través del acople 
de los tres anticuerpos al soporte. 
Palabras clave: IgY, anticuerpo, glu-
tamato, NMDA, subunidad NR1, croma-
tografía de afinidad, purificación.
REsumO
A produção de anticorpos policlonais 
(IgY) em galinhas tem vantagens so-
bre os obtidos em outros modelos ani-
mais e eles têm sido usados  como uma 
ferramenta para o estudo de proteínas 
diferentes (NMDA receptor de gluta-
mato no nosso caso, especificamente a 
subunidade NR1). Nós produzimos an-
ticorpos específicos contra produtos de 
expressão pela splicing alternativo do 
gene que codifica receptor NMDA subu-
nidade NR1 no cérebro de ratos adultos. 
Três peptídeos correspondentes aos lo-
cais de splicing (N1, C1 e C2’ cassetes) 
foram concebidos, sintetizados e utiliza-
dos individualmente como antígenos em 
galinhas. Imunoglobulinas específicas 
foram purificadas a partir de gemas. Os 
anticorpos foram então usados para puri-
ficar o receptor NMDA subunidade NR1 
utilizando cromatografia de afinidade, 
por meio da junção dos três anticorpos 
ao suporte. 
Palavras-chave: IgY, anticorpo, glu-
tamato, NMDA, subunidade NR1, cro-
matografia de afinidade, purificação.
InTRODuCTIOn
Chickens IgG (IgY) have some physico-
chemical characteristics differentiating 
them from mammals IgG (1). For exam-
ple, they do not interact with rheumatoid 
factors, do not activate the human com-
plement system, do not bind to Staphylo-
coccus sp. protein A, protein G nor to 
mammalian cells Fc receptors in such a 
way that the probability of false positives 
being given in immunological assays be-
comes greatly reduced (2, 3, 4).
In nature, IgYs are found in two 
forms: one is complete and the other 
truncated. Both can coexist in a single 
individual as happens in some turtles and 
in ducks (5). The complete form has a 
180 kDa molecular mass and (like all low 
weight immunoglobulins) two heavy (H) 
and two light (L) chains. The H chains 
have both variable (V) and constant (C) 
regions with four immunoglobulin do-
mains, thus explaining their large size 
(6). The truncated form has a 120 kDa 
molecular weight as it has lost its CH3 
and CH4 domains from the H chains, 
making into an F(ab’)2-like fragment 
molecule.
Ionotropic Glutamate receptors are 
directly related to long-term potentia-
tion (LTP) processes such as memory 
and learning. This type of receptor has 
been subdivided into three groups due 














to the use of different external agonists; 
these groups are known as N-Methyl-D-
Aspartate (NMDA), AMPA and Kainate, 
they seem to have great similarity struc-
turally and functionally, even though the 
processes in which they intervene could 
be different or complementary.
The NMDA receptor consists of se-
veral subunits known as NR1, NR2 and 
NR3, the first two being the most studied 
due to their greater presence in functional 
receptors. Previous studies have shown 
that the receptor functions as a channel 
as long as it has at least one NR1 subunit 
in its conformation (7).
The NR1 subunit has eight isoforms 
due to the presence of alternative spli-
cing in three of the exons of the gene pro-
ducing this protein. These segments are 
called N1, C1 and C2 even though the 
latter might be present or not, leading to 
the appearance of an additional segment 
called C2’ which is only found in case C2 
is not present (7). 
mATERIALs AnD mETHODs
The segments corresponding to each NR1 
subunit splicing site were identified (N1, 
C1 and C2’ cassettes). Peptides corres-
ponding to each of them were then de-
signed. These peptides were synthesised 
at Fundación Instituto de Inmunología de 
Colombia synthesis laboratory (FIDIC) 
and used as antigens for producing IgYs. 
Once the peptides had been obtained, Hi-
Line Brown hens were immunised.
Peptide synthesis
Each peptide was synthesised by the 
solid phase method, following Boc-
strategy in polypropylene bags (Biotech. 
Instruments, USA), using 4-methylben-
zylhydrilamin resin (MBHA) (100-200 
mesh, 1-1,2 mmol/g, Fluka, Switzerland) 
(8). Boc-Lys(Fmoc)-OH (BACHEM, 
Switzerland) was used in the synthesis in 
the peptide’s amino terminal position to 
avoid modifying this residue’s side chain 
group. Temporary protection (Boc), in-
cluding that of the NH2-terminal, was eli-
minated by treatment with 37.5 % trifluo-
roacetic acid (TFA) in dichloromethane 
(DCM). 0.2 M acetic acid in DCM was 
used for acetylating the peptide’s amino 
terminal following activation coupling 
with 1,3-diisopropylcarbodiimide (DIC) 
methodology. Low-High HF procedure 
was used for final deprotection; pure HF 
(fluorhydric acid) was used for analysis. 
The bag was then washed with diethyl 
ether and vacuum-dried. The peptide was 
extracted from crude final product with 
30 % acetic acid (AcOH). The final ex-
tract was diluted with water and lyophili-
sed. Synthesis products were determined 
by high resolution liquid chromatogra-
phy (HPLC) using a 5-60 % acetonitri-
le gradient (0.1 % TFA) in water for 30 
min. the peptide was detected by its ab-
sorbance in ultraviolet and it was charac-
terised by MALDI-TOF mass spectro-
metry (Voyager), using a lineal operation 
mode (2,000V acceleration voltage and 
100 shots per spectrum).
Using peptides as antigens
Twelve 16-week old hens (3 per pep-
tide and 3 controls) were used which 
had been conditioned for two weeks in 
individual cages with food available ad 
libitum. Once this time had elapsed the 
animals were kept in the same conditions 
until they began to lay eggs and their pro-
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duction became regularised at 1 egg per 
day (at around week 20). The peptides 
began to be inoculated at this time. The 
chickens were immunised (9, 10), the an-
tigen having been previously emulsified; 
this involved preparing solutions of each 
peptide (1.8 mg dissolved in 2 ml 50 mM 
phosphate buffer, pH 7.5) to which 2.5 
ml Freund’s complete adjuvant (Sigma) 
was slowly added, homogenising it later 
on. This solution (around 1.0 ml) was in-
tramuscularly injected into several areas 
of the pectoral region. Two boosters were 
applied using the same amount of pep-
tide at 10-day intervals using Freund’s 
incomplete adjuvant.
The eggs were collected daily and 
kept at 4 ºC until being used in extrac-
tion. The selection was made according 
to the peptide used as antigen and the 
days post-inoculation.
Extracting and purifying IgY
Lipids were removed from the yolks fo-
llowing the previously described method 
(11), a precipitate being obtained at the 
end of the process mainly consisting of 
lipids and a supernatant in which most 
proteins were found, including the IgY. 
60 % s (NH4)2SO4 was used with constant 
shaking at 4 ºC for 3 hours for precipi-
tating the proteins from the supernatant. 
Once this time had elapsed, the solution 
was centrifuged at 18,000 rpm for 30 mi-
nutes at 4 ºC; the pellet was suspended in 
distilled water (about a tenth part of the 
initial volume) and kept at -20 ºC.
The activity of the antibodies present 
in the eggs from the first day of inocu-
lation was determined by ELISA assay 
(12) using the corresponding peptides 
as antigens (5 mg in carbonate buffer, 
pH 9,6); the protein extracts so obtained 
(IgY) were not diluted. The samples pre-
senting the greatest activity were used 
for purifying total IgY; this was done by 
thiophilic chromatography using adsor-
bent T-gel as support (Pierce ™) (12, 13). 
The columns used were packed and ac-
tivated according to the manufacturer’s 
recommended procedure. The columns 
were then equilibrated with four volumes 
of binding buffer (0.5 M Na2SO4, 50 mM 
Na3PO4, pH 8.0, 0.05% NaN3). The sam-
ple was dissolved in 0.5 M Na2SO4 and 
allowed to totally soak into the gel. The 
column was washed with 13 volumes of 
binding buffer, collecting around 3 ml 
fractions and monitoring the presence 
of non-retained material by absorbance 
at 280 nm. About 12 volumes of elution 
buffer (50 mM Na3PO4, pH 8.0, 0.05% 
NaN3) were used for eluting the IgYs (re-
tained material), determining protein pre-
sence by reading absorbance at 280 nm. 
The support was regenerated according 
to the manufacturer’s recommendations. 
The fractions so obtained were analysed 
by electrophoresis (PAGE-SDS) accor-
ding to (14).
Affi-Gel-10 and Affi-Gel-15 (Bio-
Rad) were used for purifying specific 
IgYs; they were separately coupled (15) 
to each of the corresponding peptides 
according to the manufacturer’s recom-
mendations (aqueous coupling). 2 ml 
Affi-Gel were washed with 3 volumes 
of cold distilled–deionised water (4 ºC). 
The support was then equilibrated with 
sodium phosphate buffer (0.1 M NaH-
2PO4, 0.1 M Na2HPO4, pH 7.5) which 
was used as ligand solvent. 0.5 ml of the 
solution containing ligand (1 mg/ml) was 
added and kept overnight with constant 














shaking. Once this time had elapsed, the 
column was packed and washed with the 
same buffer. The procedure above was 
repeated until absorbance was found 
on the base line again, but 0.1 M Gly 
in phosphate buffer was used instead of 
peptide as blocking agent for binding si-
tes which had not been occupied by the 
peptide. 
The columns were washed with 
phosphate buffer and equilibrated with 
buffer PBS (0.1 M NaH2PO4, 0.1 M 
Na2HPO4, 150 mM NaCl, pH 7.5); the 
IgY samples were then applied (close to 
2 mg of protein) dissolved in the same 
equilibrium buffer. The sample was elu-
ted with PBS and the material retained 
was eluted with 0.5 M AcOH when all 
the non-retained material had been obtai-
ned, 1 ml fractions being collected. 
The support was washed with cold 
deionised water and conserved in 0.1 M 
sodium phosphate buffer, pH 7.5 at 4 ºC. 
The retained fractions (IgY–antipepti-
de) were concentrated by ultrafiltration 
(Amicon YM 10), evaluated by ELISA 
assay (using peptides as antigens) and by 
PAGE-SDS following transfer to nitroce-
llulose membrane; protein concentration 
was determined by the bicinchoninic acid 
method (BCA) (16). The fractions were 
transferred to nitrocellulose membrane 
(45 µm, BioRad) according to (17), using 
48 mM Tris, 39 mM Gly, 20 % metha-
nol, pH 9.3 as transfer buffer, 80 minutes 
transfer time at 100 V and 350 mA. Once 
this time had elapsed, the nitrocellulose 
membranes were blocked overnight with 
5 % PBS-skimmed milk at 4 ºC and then 
washed thrice with PBS- 0.1 % Tween 
20, followed by a 2-hour incubation at 
37 ºC with the corresponding secondary 
antibody (peroxidase-coupled anti-hen 
IgG, Sigma) diluted 1:2,000 in 5 % PBS-
milk, for 2 hours at 37 ºC. They were 
washed again with TBS-Tween 20 and 
30 ml fresh revealing solution was added 
(15 mg tetrahydrochloride 3,3’-diamino-
benzidin (DAB) in 30 ml PBS buffer, pH 
7.2, plus 30 µL H2O2). 
Once the presence of IgYs had been 
demonstrated, their specificity for re-
cognising NR1 subunit was determined; 
PAGE-SDS of crude rat brain extract was 
thus carried out and transfer to nitroce-
llulose membrane was done according 
to previously mentioned conditions. Fo-
llowing blocking with 5 % PBS-skim-
med milk, the corresponding washes 
with PBS-Tween 20 were done and each 
membrane was incubated overnight with 
the primary antibodies (previously puri-
fied anti-N1, anti-C1 and anti-C2’ were 
used separately) at 4 °C. Each membrane 
was then washed twice with PBS-Tween 
20 followed by 2-hour incubation at 37 
ºC with the corresponding secondary 
antibody (peroxidase-coupled anti-hen 
IgG, Sigma) diluted 1:2,000 in 5 % PBS-
milk for 2 hours at 37 ºC. They were 
washed again with TBS-Tween and 30 
ml fresh revealing solution were added 
(15 mg DAB in 30 ml PBS buffer, pH 
7.2, plus 30 µL H2O2) (18).
Purifying nmDA receptor nR1 
subunit 
The 3 anti-peptide antibodies were cou-
pled to the Affi-Gel support in the same 
conditions previously described for cou-
pling the peptides (15). The amount of 
antibodies was around 600 µg (200 µg 
of each purified antibody) coupled to 2 
ml resin and coupling proceeded for 12 
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hours at 4 ºC with circular movements. 
Once this time had elapsed, the support 
was washed with PBS pH 7.5, glycine 
solution was added (0.1 M in PBS) and 
it was incubated for 12 hours at 4 ºC with 
circular movements. The support was 
then washed and equilibrated with 0.1 % 
Triton x-100 in PBS buffer, pH 7.5.
The sample (adult rat brain extract 
prepared according to 18), previously 
dialysed against the equilibrium buffer, 
was put on the column (1 ml sample 
(3.5 mg/ml)) and incubated for at least 2 
hours at 4 ºC (or overnight in some ca-
ses). Once this time had elapsed, the non-
retained material was eluted with equili-
brium buffer (PBS pH 7.5, 0,1% Triton 
x-100) until absorbance at 280 nm again 
reached the base line. The retained mate-
rial was then eluted with 0.1 M Gly pH 
2.4, 0.1 % Triton x-100, the presence of 
protein being monitored by absorbance 
at 280 nm. The fractions so collected 
(800 µL each) were immediately neutra-
lised by adding 200 µL 0.5 M Tris pH 
8.0. Once the whole fraction retained 
from the column had been eluted, it was 
washed and equilibrated with PBS buffer 
pH 7.5 for regenerating the support.
The fractions were collected and con-
centrated by ultrafiltration using an Ami-
con YM-10 membrane. Once these frac-
tions had been concentrated, SDS-PAGE 
assays were carried out on them and they 
were transferred to nitrocellulose paper 
for determining the presence of NR1 
subunit. Transfer was done in the afore-
mentioned conditions; purified IgY was 
used as primary antibody (1:500 in 5 % 
PBS-milk) and commercial peroxidase-
coupled anti-hen IgG (Sigma) (1:2,000 
in 5 % PBS-milk) as secondary antibody. 
Incubation, washing and revealing times 
were set according to the aforementio-
ned. A commercial primary antibody was 
also used as positive control (antiNR1 
produced in goat, Santa Cruz 1:1,000 in 
5 % PBS-milk) and, in this case, the se-
condary antibody used was peroxidase-
coupled rabbit antigoat (Sigma) (1:2,000 
in 5 % PBS-milk). 
REsuLTs AnD DIsCussIOn
Designing and synthesising peptides 
used as antigens
Chickens represent a very suitable sour-
ce of antibodies (IgY) as well as offering 
an easier, faster and convenient way of 
obtaining antibodies without sacrificing 
animals and ensuring to maintain an 
almost regular production after boos-
ters have been applied (19). The greater 
phylogenetic distance was also taken into 
account when selecting the animal mo-
del, since birds should be a good model 
for producing specific antibodies if the 
NMDA receptor were found to be con-
served amongst mammals. The search 
regarding the presence of NR1 subunit 
in Gallus gallus revealed only sequen-
ces corresponding to computational pre-
dictions of subunit NR2B (xP416204), 
NR3B (xP426726), NR2D (xP427751)-
like proteins; however, no reports were 
found for the NR1 subunit sequence in 
this organism.
Each subunit isoform sequence has 
been reported in GenBank (http://www.
ncbi.nlm.nih.gov/Entrez) as a concep-
tual translation of messenger RNA found 
in different areas of the brain. Multiple 
alignment (ClustalW) was used for de-
termining the sequence corresponding 














to each splicing-site product, these being 
the basis for designing the peptides used 
as antigens for producing polyclonal an-
tibodies (Table 1).
These peptides were selected since 
predicting antigenicity (20) could pro-
duce a better immune response in the 
animals which were inoculated. Accor-
ding to secondary and tertiary structure 
prediction it was possible that their fol-
ding led to their great ability to produce 
an immune response since they probably 
had an α-helix configuration leading to 
several of their amino acid side chains 
interacting with the medium, thereby 
producing a good immune response.
Peptides N1, C1 and C2´ were 
synthesised at FIDIC following the abo-
ve analysis. MALDI-TOF mass spectro-
metry N1 peptide characterisation revea-
led the highest HPLC peaks (close to 95 
%) corresponding to 2,554.9, 2,572.9 
and 2,663.7 Da species, having 1.1 Da, 
19.1 Da and 109.9 Da difference, respec-
tively, respecting the peptide’s calculated 
molecular weight (2,553.8 Da). Such 
differences could have been due to the 
presence of a proton (1.1 Da), 1 water 
molecule plus a proton (19.1 Da) and 6 
water molecules (109.9 Da). 
The mass spectrum obtained for pep-
tide C1 showed that the greatest intensi-
ty compound presented species having 
4,208.9 Da, 4,214.8 Da and 4,219.1 Da 
molecular weights, having 27.2 Da, 33.1 
Da and 37.4 Da differences, respectively, 
regarding predicted molecular weight 
(4,181,7 Da). Such differences could 
have been due to contaminant metallic 
ions, water molecules and protons being 
present in the peptide when determining 
its molecular weight. The largest com-
pound for peptide C2´ had a 1,731.2 Da 
molecular weight, presenting a differen-
ce of 17.3 Da regarding predicted mole-
cular weight (1,713.9 Da) which could 
have been due to the presence of water 
molecules.
Designing peptides from N1, C1 and 
C2’ segments corresponded to sequences 
which had been previously reported (21), 
even though a difference in an amino 
acid was presented in the C2 peptide pro-
posed by ourselves. Their great tendency 
to fold themselves into α-helices became 
apparent when predicting each peptide’s 
tertiary structure, a situation which was 
not strange as this is one of the most sta-
ble conformations which a short amino 
acid sequence can adopt, such as that 
existent in each segment. However, due 
to their short extension, it could not be 
ignored that the structure might adopt a 
different form in the aqueous medium 
in which amino acids are dissolved. If 
it were accepted that the tridimensional 
structure were so, then this would be a 
good factor for amino acid side chains to 
interact with the medium in which they 
are found and produce a good immune 
response.
Peptide antigenicity was also pre-
dicted using Abie Pro 3.0: Peptide An-
tibody Design 8 software (http://www.
changbioscience.com/abie/abie.html); it 
was found that peptide N1 was probably 
antigenic since it presented 9 highly anti-
genic internal segments (22), or 2 accor-
ding to Kyte and Doolittle´s scale (23). 9 
and 4 segments were present for C1 (ac-
cording to the same scales) but only one 
antigenic site was present in C2’, even 
though its extension was greater than that 
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of the segments predicted for the other 
peptides. However (according to all the 
results) the peptide having the greatest 
probability of being antigenic was C2’ 
since it presented the greatest percenta-
ge of amino acids which could become 
antigenic due to their location and hydro-
phobicity.
Extracting IgY
The chickens were immunised after the 
10th egg-laying day, such time being 
when they all maintained regular produc-
tion; thereby, inoculation did not affect 
production leading to the deduction that 
animal-handling was suitable and did not 
produce a high degree of stress in them. 
No alteration was observed in the ani-
mals’ egg-laying when the two boosters 
were applied.
The procedure used led to extracts 
being obtained having 5 to 10 mg/ml 
protein concentration and an electropho-
retic profile mainly revealing 60 to 70 
kDa and 20 to 30 kDa molecular weight 
proteins (data not shown). These results 
were obtained for all the extracts, indi-
cating the procedure’s convenience for 
obtaining IgYs from egg-yolks.
ELISA was used for determining 
the presence of specific IgY against the 
three peptides using samples from eggs 
collected from the day after inoculation, 
counting this as being day 1. The results 
obtained from the samples from the first 
ten days showed that IgY concentration 
tended to increase towards the 8th day of 
beginning to produce specific antibodies 
against the inoculated peptides (data not 
shown).
Figure 1 shows the response obtai-
ned for the whole egg-collecting period. 
A maximum response was observed for 
peptide N1 towards day 25 (Figure 1A), 
followed by a decrease but recovering 
following day 40 (20 days after the 2nd 
booster). Peptide C1 (Figure 1B) pre-
sented behaviour in which there was a 
transitory increase towards day 25 and 
then the response remained constant (at 
lower levels) until day 55. The highest 
responses were obtained with peptide 
C2’ (Figure 1C) 20 days after the second 
booster, such response being maintained 
until the end; this result ratified predicted 
antigenicity according to which C2’ was 
shown to be the most antigenic of the se-
lected peptides. 
When the peptides were used as an-
tigens, the presence of antibodies was 
directly identified in the egg-yolk. As the 
yolk consists of around 50 % of material 
which is insoluble in water, the first step 
in extracting IgY involved separating sol-
uble proteins in water from the rest of the 
material found in the yolk. This process 
has been described using different buffers 
(9, 11) or an “aqueous dilution of acetic 
acid” (9, 24); however, in our case we 
opted for extraction with water follow-
ing results obtained by (12), HCl being 
added until 5.0 pH was obtained, since 
IgY were thereby recovered eliminating 
the greatest possible amount of lipids and 
hydrophobic molecules, obtaining a clear 
solution having a high concentration of 
proteins presenting bands characteristic 
of IgY H and L chains (12, 24). Adding 
60 % s (NH4)2SO4 to supernatant caused 
precipitation of thiophilic chromatogra-
phy-purified IgY (13, 25) facilitating ob-
taining specific IgY.














Figure 1. Determining the presence of anti-
N1 (A), anti-C1 (B) and anti-C2´ antibodies 
(C) in egg-yolk extracts by ELISA assay. On 
the x axis the days after inoculation are shown 
and on the and on the Y axis the absorbance at 
415nm determined in the ELISA assay.
Purifying total IgY
IgY was separated from control hens 
yolks (not having been inoculated) in an 
initial assay, observing (Figure 2) that 
the amount of IgY in the extract was high 
since the fractions retained by the T-Gel 
column were greater than those fractions 
not retained by this support.
Figure 2. Thiophilic chromatography of a 
sample of egg-yolk from control chickens. 
The fractions marked I, III and IV were analy-
sed by ELISA assay. (Binding buffer: 50mM 
sodium phosphate, 0,5M potassium sulpha-
te, pH 8,0; Elution buffer: 50mM sodium 
phosphate pH 8,0)
Similar chromatographic profiles were 
observed for the extracts from immuni-
sed hens. It was observed in the case of 
the extract called N1 (non-purified IgY 
anti- N1pool) that the retained fractions 
absorbance value was around 1.3, indica-
ting high protein content. A similar pat-
tern was obtained with extracts C1 and 
C2’, retained fraction´s absorbance rea-
ching values around 0.8. In these three 
cases, the greatest variation was presen-
ted in the area of elution of the material 
which was not retained by the support, 
since some cases presented just a single 
peak having very high value and others 
presented several peaks having inter-
mediate absorbance values. The presen-
ce of proteins having similar molecular 
weights to the IgY H and L chains were 
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revealed in the retained fractions by PA-
GE-SDS.
Purifying specific IgY 
IgYs directed against peptides were pu-
rified by affinity chromatography using 
N1-AffiGel 10, C1-AffiGel 10 or C2´-
AffiGel 15 as supports. The amount of 
recovered protein (according to each re-
tained fractions absorbance, see Figure 
3) was very similar in all three cases sin-
ce maximum value was close to 0.3 ab-
sorbance units for all of them. It is worth 
noting that in all assays carried out the 
retained fraction presented 3 to 4 poorly-
resolved peaks presenting activity by 
ELISA assays, meaning that they were 
put into a single pool.
Electrophoresis of the retained and 
non-retained fractions for the three thio-
philic chromatographies (Figures 3A, 
3B, 3C) revealed that immunoglobulin 
Figure 3. Affinity chromatography of IgY fractions retained in thiophilic chromatography using 
peptide N1 (A), C1 (B) and C2’ (C) coupled to Affi-Gel 10 (A,B) and Affi-Gel 15 (C), respecti-
vely. (D) PAGE-SDS, Coomasie blue staining of IgY anti-N1 (lanes 2 and 5), IgY anti-C1 (lanes 
3 and 6) and IgY anti-C2’ (lanes 4 and 7); lane 1: molecular weight markers. 
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concentration in the non-retained frac-
tion was much greater than that present 
in the fraction retained, which was to be 
expected given that they corresponded to 
non-specific IgY.
Pools from different chromatography 
(done with the same ligated peptide) were 
put together to better show proteins pre-
sent in the retained fraction; these were 
concentrated 50-fold by ultrafiltration 
and analysed by PAGE-SDS. The bands 
corresponding to the H and L chains of 
each specific IgYs produced may be seen 
in Figure 3D. 
Alternative splicing products were 
recognised by specific antibodies for 
each of them in Western blot assays on 
adult rat brain extract (Figure 4) where 
the binding of the three produced anti-
bodies (IgYs) to proteins having close 
to 130 kDa molecular weight was seen, 
as reported for NR1 subunit molecular 
weight (7).
Figure 4. Western blot of a partially purified 
brain extract using anti-N1(A), anti-C1 (B) 
and anti-C2’ (C) antibodies for recognising 
it. The arrow indicates the presence of NR1 
subunit
Using N-hydroxy-succinimide esters as 
active groups for forming amide bridges 
with primary amines has been used for 
ligating antigens to supports and thus pu-
rifying antibodies. Several supports have 
been used, but in our case we used Affi-
Gel 10 and Affi-Gel 15. An uncharged 
spacer was incorporated with Affi-Gel 
10 (this being recommended for basic 
or neutral proteins having 6.5 to 11 iso-
electric points). Affi-Gel 15 has a spacer 
arm having a positively-charged nitrogen 
(recommended for proteins having iso-
electric points less than 6.5) (15).
Purifying nR1 subunit
Given that IgY did not bind to protein A 
or protein G, as happens with mammals’ 
immunoglobulins, NR1 subunit was affi-
nity purified with IgY-AffiGel support. 
NR1 subunit from rat brain extracts (after 
being incubated with antibody coupled to 
the support) presented an elution profile 
(Figure 5A) in which most proteins were 
eluted in the non-retained fraction whilst 
the retained fraction (eluted by adding 
glycine solution, pH 2.4) clearly had less 
and contained NR1 subunit according to 
ELISA determination. 
Given that protein concentration in 
retained fractions was very low, they had 
to be precipitated with absolute ethanol 
at -20 ºC, since concentration by ultra-
filtration did not allow the bands corres-
ponding to NR1 subunit to be observed 
by PAGE-SDS (Figure 5B). Electropho-
retic analysis of fractions precipitated 
with ethanol revealed antibody-retained 
proteins in the 130 kDa area, agreeing 
with NR1 subunit molecular weight 
(no significant percentage of additional 
bands being observed).
Final confirmation of the presence 
of NR1 subunit was obtained with im-
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cipitated with ethanol (Figure 5C) where 
it was seen that NR1 subunit correspond-
ed to the band observed in PAGE-SDS 
having a molecular weight of around 
130 kDa. Additional data of specificity 
of antibodies produced was determined 
by immunohistochemistry on rat brain 
slices; MALDI-TOF MS determinations 
of affinity-purified NR1 subunit (data 
not shown) corroborated the purity of 
the protein. It is worth mentioning that 
this separation was achieved by using 
the three antibodies coupled to the same 
support and that possibly the three anti-
bodies’ multiple interaction with NR1 
subunit increased efficiency in separa-
tion from the subunit due to the great 
probability that this was a homomeric 
complex, being corroborated by the sin-
gle band found in the electrofocusing 
done on this sample (data not shown).
Regarding the subunit’s separation 
from the receptor, it should be noted that 
it has been proposed that the different 
subunits could be separated by using the 
Figure 5. (A) Affinity chromatography of partially purified adult rat brain extract using IgYs 
(antiN1, antiC1 and antiC2’) coupled to Affi-Gel 15. The shaded region represents the fraction 
having the greatest activity in ELISA assay. (B) PAGE-SDS of fractions retained from the affinity 
columns using IgY’s coupled to Affi-Gel 15 support. Lanes 1, 5 and 9: molecular weight markers; 
lanes 2, 6 and 10: partially purified extract (before using affinity chromatography); lanes 3, 7 
and 11: fractions retained by affinity chromatography concentrated by precipitation with ethanol; 
lanes 4, 8 and 12: fractions retained by affinity chromatography concentrated 10 times by ultra-
filtration. The amount of sample applied was 20 ml (lanes 2-4), 10 ml (lanes 6-8), 5 ml (lanes 10-
12). The arrow indicates the possible presence of NR1 subunit. (C). Western-blot of NR1 subunit 
purified by affinity using IgYs coupled to Affi-Gel 15. Subunit presence was corroborated by 
using a commercial antibody (Anti-NR1).
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antibodies produced; however, no de-
scription of the separation of any of them 
has been reported to date. Evidence has 
been brought forward (21) supporting the 
presence of a relatively high amount of a 
pool of unassembled NR1 in brain. NR1 
subunit could thus coexist with an assem-
bled homomeric complex or as a simple 
subunit being ready to bind to NR2 sub-
units. The fact that particular mRNA 
from NR1 could produce a functional re-
ceptor in oocytes indicates that NR1 sub-
unit could form a homomeric complex 
receptor in certain conditions, (26, 27). 
However, a functional homomeric recep-
tor cannot be formed in transfected cells, 
even though it seems that NR1 subunit 
could form a complex receptor having 
binding sites for co-agonist glycine. As 
unassembled NR1 subunits seem not to 
be expressed on a neuron’s surface (28), 
then the presence of a pool in excess of 
NR1 implies that NR2 subunits expres-
sion defines the NMDA receptor’s func-
tional properties and that NR2 subunits 
are more finely regulated than NR1 sub-
units regarding regional expression and 
development level (28, 29).
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